Dynamic Blood Clot Model for Coagulation Monitoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Contemporary blood coagulation monitoring systems overwhelm healthcare providers with excessive data, making it difficult to quickly and accurately understand a patient's blood coagulation status, which is crucial for timely and correct medication administration.

Innovation Solution

A computer-generated, dynamic two- or three-dimensional synthetic blood clot model is created to visually represent coagulation data, allowing for easier comprehension and integration with conventional monitoring devices or as a hologram, providing a user-friendly interface for healthcare professionals and consumers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If multiple coagulation parameters are monitored and displayed, then measurement precision and diagnostic capability are improved, but device complexity and information overload increase

Engineering Contradiction:
Improvecoagulation function measurementVSAvoidmonitoring system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple coagulation parameters (clot formation, strength, lysis, drug effects) into a single integrated visual blood clot model representation. This merging approach allows comprehensive monitoring of coagulation function while presenting information in a unified, non-overwhelming format that healthcare providers can quickly comprehend.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The visual blood clot model acts as an intermediary between the complex raw coagulation data and the healthcare provider's understanding. Instead of directly presenting numerous numerical parameters, the system uses a visual synthesis that mediates the information, making it accessible and actionable for clinical decision-making.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If comprehensive coagulation data is presented in detail, then measurement precision is improved, but ease of operation and decision-making speed deteriorate

Engineering Contradiction:
Improvecoagulation status assessmentVSAvoidinterpretation ease
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The visual blood clot model employs color variations to represent different coagulation states and parameters. Color changes provide an intuitive visual language that allows healthcare providers to quickly assess coagulation status without needing to interpret complex numerical data, thereby improving ease of operation while maintaining measurement precision.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The patent transforms multi-dimensional coagulation data into a visual three-dimensional blood clot model representation. This dimensional transformation allows comprehensive information to be perceived at a glance through spatial and visual cues rather than requiring linear analysis of multiple parameters, significantly improving interpretation ease.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Device complexity

If traditional coagulation monitoring displays are used, then device complexity is kept simple, but loss of information and diagnostic accuracy increase

Engineering Contradiction:
Improvemonitoring device simplicityVSAvoidcoagulation function information
Core Design Contradiction:
Device complexityVSLoss of information

Solution Approach 1:

The system merges multiple coagulation parameters into a single visual representation that captures the essential information about clot formation, strength, stability, and drug effects. This combining approach prevents information loss by integrating comprehensive data while maintaining a simple, unified display that does not overwhelm the user.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS20220172362A1Method and system for displaying and monitoring a patient's blood coagulation function
Publication Date: 2022.06.02 UNIVERSITY OF ZURICH
  • US20220172362A1 patent drawing
  • US20220172362A1 patent drawing
  • US20220172362A1 patent drawing

AI summary

Multiple streams of raw blood coagulation function data may be synthesized into a single display or instrument, showing a synthetic model of a blood clot, which is generated according to algorithms and rendered dynamically in real time by a graphics processor. Dynamic alterations in the states or attributes of specified parts of a displayed blood clot may be used. The dynamic alterations involve, but are not limited to, the shape of parts, changes in the volume of parts, in a three-dimensional representation, or the area of parts, in a two-dimensional representation, number and movement of parts, and changes in the color of parts. The blood clot may be looked at from all angles according to user input. The dynamically altered parts of the visual clot model may include background, drug indicator, fibrin mesh indicator, plasmatic coagulation factor indicator, blood drops and pool of blood indicator, and platelet indicator.